KYPHA INC.

Profile

Company Names

KYPHA INC.

Addresses

4340 DUNCAN AVENUE, SUITE 204, SAINT LOUIS, MO 63110

4320 FOREST PARK AVENUE, SUITE 303, ST. LOUIS, MO 63108

4320 FOREST PARK AVENUE, SUITE 303, SAINT LOUIS, MO 63108

Phone Numbers

314-282-2008
314-932-4032 EXT 313

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$15,212,895.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2022-04-08 
$5,150,000.00 
$17,000,000.00 
$11,850,000.00 
Equity 
7
2018-06-19 
$950,000.00 
$950,000.00 
$0.00 
Equity 
6
2018-04-30 
$5,457,515.00 
$7,852,883.00 
$2,395,368.00 
Equity 
5
2015-02-20 
$2,101,005.00 
$3,201,005.00 
$1,100,000.00 
Debt 
4
2013-12-30 
$398,375.00 
$3,500,000.00 
$3,101,625.00 
Equity 
3
2013-03-01 
$750,000.00 
$750,000.00 
$0.00 
Equity 
2
2012-06-25 
$200,000.00 
$1,500,000.00 
$1,300,000.00 
Equity 
1
2011-11-22 
$206,000.00 
$500,000.00 
$294,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GERHARD 
 
BETTE 
DIRECTOR
T. 
VERNON 
FOSTER 
DIRECTOR
T. 
SCOTT 
GLOVER 
EXECUTIVE OFFICER
JAMES 
D. 
MARSELIS 
DIRECTOR
SULTAN 
 
MEGHJI 
DIRECTOR
JAMES 
 
MERSELIS 
DIRECTOR
R. 
CHARLES 
MOYER 
DIRECTOR
PAUL 
K. 
OLSON 
EXECUTIVE OFFICER, DIRECTOR
PETER 
 
REINECKE 
DIRECTOR
JONATHAN 
 
SACKIER 
DIRECTOR
NICK 
 
STATEN 
EXECUTIVE OFFICER
CHAD 
 
STIENING 
DIRECTOR, EXECUTIVE OFFICER
CHAD 
M. 
STIENING 
EXECUTIVE OFFICER, DIRECTOR
PETER 
A. 
TAKES 
EXECUTIVE OFFICER
DENNERT 
 
WARE 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2022-04-08 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-19 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-30 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-30 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2015-02-20 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#